Elgia Therapeutics, a venture-backed biopharmaceutical company, is positioned to deliver first-in-class and best-in-class therapies for serious chronic diseases, such as fibrosis, neuroinflammation, NASH, kidney disease, and inflammatory bowel disease (IBD). The Elgia team has discovered how metabolic stress drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery. By combining these pioneering biological insights with R&D expertise, Elgia is creating innovative medicines for debilitating chronic diseases.
Company Details
- Employees
- 3
- Founded
- -
- Address
- San Diego, California 92121, Us
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- elgiatherapeutics.com
- HQ
- San Diego, California
Elgia Therapeutics, Inc. Questions
Elgia Therapeutics, Inc.'s website is elgiatherapeutics.com
Elgia Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/elgiatherapeutics
Elgia Therapeutics, Inc. has
3 employees.
View email and phone details for 3
employees at Elgia Therapeutics, Inc..
Elgia Therapeutics, Inc.'s industry is
Biotechnology Research
Elgia Therapeutics, Inc.'s top competitors are
Biocellgene Consulting Ltd.,
Chimagen Biosciences,
Sunesis Pharmaceuticals, Inc.,
Protego Bio,
Tatara Therapeutics,
Quanta Therapeutics,
Ambagon Therapeutics,
Novomedix,
Jecure Therapeutics,
Nul Consulting Llc.
Elgia Therapeutics, Inc.'s support email address is info@elgiatherapeutics.com
Elgia Therapeutics, Inc.'s categories are Biotechnology Research
Elgia Therapeutics, Inc.'s founding year is 2019
